EFFICACY OF PROPRANOLOL IN TRAUMATIC BRAIN INJURY PATIENTS ADMITTED TO THE ICU: A PROSPECTIVE, RANDOMIZED, TRIPLE-BLIND STUDY (ProP TBI in ICU)

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-524194-17-00

Enrollment

600

Registered

2026-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head injury

Brief summary

Hospital mortality

Detailed description

Glasgow outcome scale extended

Interventions

DRUGMETHYLCELLULOSE

DRUGPropranolol 40 mg Tablets

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Hospital mortality	—

Secondary

Measure	Time frame
Glasgow outcome scale extended	—

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 6, 2026